<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30416383</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Electronic">1449-2288</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>14</Volume>                    <Issue>12</Issue>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>International journal of biological sciences</Title>                <ISOAbbreviation>Int. J. Biol. Sci.</ISOAbbreviation>            </Journal>            <ArticleTitle>Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation.</ArticleTitle>            <Pagination>                <MedlinePgn>1686-1695</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.7150/ijbs.27599</ELocationID>            <Abstract>                <AbstractText>Identifying markers for breast cancer is important for both diagnosis and the design of treatment strategies. Recent studies have implicated Paired box 5 (<i>PAX5</i>) as a suppressor in various cancer types, where it is silenced by hypermethylation. However, determining the role of <i>PAX5</i> in breast cancer requires further study, and the relationship between <i>PAX5</i> methylation and breast cancer remains unclear. In this study, we found that <i>PAX5</i> expression was frequently silenced or reduced by methylation in breast cancer cell lines as well as in breast cancer tissues. Restoring expression of <i>PAX5</i> in breast cancer cells led to tumor suppression through inhibited proliferation and invasion, which resulted from modulation of the cell cycle and altered vascular endothelial growth factor (VEGF) expression. Most importantly, we found that <i>PAX5</i> methylation status in breast cancer tissues was significantly correlated with patients' age, estrogen receptor (ER) status, progesterone receptor (PR) status, indicating that <i>PAX5</i> could serve as a marker for breast cancer diagnosis and treatment strategy design.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Xia</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Huang</LastName>                    <ForeName>Jianbo</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Luo</LastName>                    <ForeName>Xinrong</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Dejuan</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yin</LastName>                    <ForeName>Xuedong</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Peng</LastName>                    <ForeName>Weiyan</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bi</LastName>                    <ForeName>Can</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ren</LastName>                    <ForeName>Guosheng</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Endocrine and Breast Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xiang</LastName>                    <ForeName>Tingxiu</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Chongqing Key Laboratory of Molecular Oncology and Epigenetics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>07</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Australia</Country>            <MedlineTA>Int J Biol Sci</MedlineTA>            <NlmUniqueID>101235568</NlmUniqueID>            <ISSNLinking>1449-2288</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2007 Mar 8;26(11):1645-9</RefSource>                <PMID Version="1">16964282</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Blood. 2015 Jun 4;125(23):3609-17</RefSource>                <PMID Version="1">25855603</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Immunol. 2007 May;8(5):463-70</RefSource>                <PMID Version="1">17440452</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2012 Jul 05;14(4):R101</RefSource>                <PMID Version="1">22765268</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Mol Med. 2012 Jan;12(1):96-110</RefSource>                <PMID Version="1">22082486</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 1995 Jan;1(1):27-31</RefSource>                <PMID Version="1">7584949</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2694-700</RefSource>                <PMID Version="1">19789364</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Dove Med Press). 2017 Dec 06;9:567-579</RefSource>                <PMID Version="1">29263697</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2010 Mar;8(3):444-56</RefSource>                <PMID Version="1">20197384</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2001 Sep 15;61(18):6952-7</RefSource>                <PMID Version="1">11559575</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2016 Jan;155(1):13-23</RefSource>                <PMID Version="1">26610810</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2013 Aug;19(8):1014-22</RefSource>                <PMID Version="1">23852341</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2012 Jul 19;31(29):3419-30</RefSource>                <PMID Version="1">22105368</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Carcinogenesis. 2004 Oct;25(10):1839-46</RefSource>                <PMID Version="1">15155532</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hepatology. 2011 Mar;53(3):843-53</RefSource>                <PMID Version="1">21319196</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 1999 Jun 15;13(12):1501-12</RefSource>                <PMID Version="1">10385618</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Leukemia. 2009 Nov;23(11):1989-98</RefSource>                <PMID Version="1">19587702</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Feb 14;8(7):12052-12066</RefSource>                <PMID Version="1">28076843</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2011 Oct;225(2):222-31</RefSource>                <PMID Version="1">21710692</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Mol Med. 2018 Feb;22(2):1257-1271</RefSource>                <PMID Version="1">29193730</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2003 Aug 1;63(15):4620-5</RefSource>                <PMID Version="1">12907641</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Mol Med. 2016 May;20(5):842-54</RefSource>                <PMID Version="1">26843424</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2009 Mar 15;124(6):1338-48</RefSource>                <PMID Version="1">19058218</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jul 25;8(30):48875-48888</RefSource>                <PMID Version="1">28388578</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2003 Jul;23(13):4713-27</RefSource>                <PMID Version="1">12808109</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2009 Jun;9(6):400-14</RefSource>                <PMID Version="1">19440234</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2005 Aug 15;11(16):5678-85</RefSource>                <PMID Version="1">16115903</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2014 Mar 28;343(6178):1452-3</RefSource>                <PMID Version="1">24675948</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2007 Apr 12;446(7137):758-64</RefSource>                <PMID Version="1">17344859</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Adh Migr. 2012 Nov-Dec;6(6):547-53</RefSource>                <PMID Version="1">23257828</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Mol Med. 2013 Oct;17(10):1236-46</RefSource>                <PMID Version="1">23890219</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">PAX5</Keyword>            <Keyword MajorTopicYN="N">biomarker</Keyword>        </KeywordList>        <CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>06</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30416383</ArticleId>            <ArticleId IdType="doi">10.7150/ijbs.27599</ArticleId>            <ArticleId IdType="pii">ijbsv14p1686</ArticleId>            <ArticleId IdType="pmc">PMC6216036</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>